| Description | Myrislignan has anti-inflammatory, and anti-cancer activities, it inhibited NF-κB signalling pathway activation, inhibited the proliferation of A549 cells in a dose- and time-dependent manner, it also significantly induced apoptosis and cell cycle arrest in A549 cells. |
| molecular weight | 374.43 |
| Molecular formula | C21H26O6 |
| CAS | 171485-39-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 55 mg/mL (146.89 mM) |
| References | 1. Lu X G , Yang L , Chen J X , et al. The action and mechanism of myrislignan on A549 cells in vitro and in vivo[J]. Journal of Natural Medicines, 2016, 71(1):76. |